Clinical Trials Sponsored by Leo W. Jenkins Cancer Center

Total 862 results

Merck Sharp & Dohme LLC
University of Colorado, Denver; Memorial Sloan Kettering Cancer Center; H. Lee... and other collaborators

Completed

A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED)

Solid Tumors
Georgetown University
Memorial Sloan Kettering Cancer Center; City of Hope Medical Center; Indiana... and other collaborators

Recruiting

Older Breast Cancer Patients: Risk for Cognitive Decline (TLC)

Cognitive Decline | Cancer, Breast | Age-related Cognitive Decline

United States
H. Lee Moffitt Cancer Center and Research Institute
Kyowa Hakko Kirin Pharma, Inc.

Recruiting

Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) (PLIGHT)

Mycosis Fungoides

United States
H. Lee Moffitt Cancer Center and Research Institute
United States Department of Defense

Recruiting

Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS) (STRONG-PCS)

Pancreatic Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
United States Department of Defense

Recruiting

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Urothelial Carcinoma | Non-Invasive Bladder Urothelial Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health (NIH)

Recruiting

"COACH" Study: Individualized COaching in Young Adult Cancer Survivors to Encourage Healthy Behaviors

Health Behavior

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; Gilead Sciences

Active, not recruiting

Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients

Metastatic Urothelial Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; MultiVir, Inc.

Terminated

Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer | Lung Cancer | Relapsed Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; Celgene Corporation

Completed

Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma

Melanoma

United States
Georgetown University
Wayne State University; H. Lee Moffitt Cancer Center and Research Institute

Completed

MEND 2: Making Treatment Decisions Using Genomic Testing (MEND2)

Breast Cancer Female

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; Boehringer Ingelheim

Completed

Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)

Lung Cancer | Non-small Cell Lung Cancer (NSCLC)

United States
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health (NIH)

Completed

Drug /Cue Interactions In Alcohol-Tobacco Comorbidity

Nicotine Dependence

United States
H. Lee Moffitt Cancer Center and Research Institute
United States Department of Defense

Terminated

Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan

Ovarian Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
United States Department of Defense

Completed

Promoting a Healthier Lifestyle Among Breast Cancer Survivors

Breast Cancer

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; H. Lee Moffitt... and other collaborators

Completed

Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma

Hodgkin Lymphoma

United States
Les Toises - Psychiatry and Psychotherapy Center

Recruiting

PROSPECTIVE EVALUATION OF BLOOD BIOMARKERS AS AN AID TO DIAGNOSTIC AND TREATMENT IN DRUG-NAIVE PATIENTS WITH DEPRESSION

Depressive Disorder | Bipolar Disorder | Bipolar Depression

Switzerland
Woo-Keun Seo

Not yet recruiting

Highest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients

Carotid Artery Diseases
Se-Hoon Lee

Terminated

AZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer (SUKSES-N5)

SCLC, Recurrent

Korea, Republic of
Kwang Hyuck Lee

Withdrawn

Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent

Hepatocellular Carcinoma | Cholangiocarcinoma | Gall Bladder Cancer | Obstruction of Biliary Tree | Malignant Lymphadenopathy
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Graft Versus Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma

Multiple Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute
United States Department of Defense

Recruiting

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

Pancreatic Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
United States Department of Defense

Active, not recruiting

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Breast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Residual Disease | HER2 Positive Breast Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health (NIH)

Completed

Genetic Counseling for Breast Cancer Survivors (GC for BC)

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health (NIH)

Recruiting

Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC) (BASH OPC)

Oropharyngeal Cancer | HPV-Related Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
United States Department of Defense

Recruiting

A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)

Triple Negative Breast Cancer | HER2-positive Breast Cancer | Leptomeningeal Disease

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; Jazz Pharmaceuticals

Terminated

Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC

Small-cell Lung Cancer | Relapsed Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
United States Department of Defense

Active, not recruiting

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Breast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Invasive Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | HER2 Positive Breast Carcinoma | Stage III Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; SmithKline Beecham

Completed

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma | Plasma Cell Neoplasm

United States
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health (NIH)

Completed

PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment

Prostate Cancer

United States, Puerto Rico
University of California, San Francisco
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer (VPA-FEC100)

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Johns Hopkins All Children's Hospital

Withdrawn

A Combined Cell Therapy Approach to the Treatment of Neuroblastoma

Neoplasms, Nerve Tissue | Neuroblastoma
University of Utah
Washington University School of Medicine; Cedars-Sinai Medical Center; German... and other collaborators

Recruiting

ColoCare Study - Colorectal Cancer Cohort

Colorectal Cancer

United States, Germany
Vanderbilt University Medical Center
University of Alabama at Birmingham; Emory University; H. Lee Moffitt Cancer... and other collaborators

Terminated

Risk Factors for Adult-Onset Brain Tumors

Brain Neoplasms, Benign | Brain Neoplasms, Malignant | Brain Neoplasm, Primary

United States
Marvin W. Kronenberg, M.D.
Astellas Pharma US, Inc.

Completed

Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF (HFpEF-PRoF)

Hypertension | Heart Failure, Diastolic | Diastolic Heart Failure

United States
MedsPLUS Consulting
National Institutes of Health (NIH); Lister Hill Center for Health Policy; Jenkins...

Not yet recruiting

Improving Recruitment and Retention for Diabetes Self-Management Education and Support

Diabetes Mellitus, Type 2 | Diabetes
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University; University of Washington; H. Lee...

Active, not recruiting

A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma

T Cell Non-Hodgkin Lymphoma

United States
Les Toises - Psychiatry and Psychotherapy Center

Completed

EVALUATION OF BLOOD BIOMARKER-BASED DIAGNOSTIC AID IN OUTPATIENTS SUFFERING FROM DEPRESSION

Depressive Disorder | Bipolar Disorder | Bipolar Depression

Switzerland
Eunju Lee
Bodyfriend

Completed

Clinical Effect of Massage Chair on Older Adults (SEAT)

Older Adults

Korea, Republic of
KYU-SUNG LEE
Samsung Medical Center

Completed

Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia

Overactive Detrusor | Benign Prostatic Hypertrophy With Outflow Obstruction

Korea, Republic of
Se-Hoon Lee

Unknown

Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy (LC_Biomarker)

Lung Cancer

Korea, Republic of
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center; Mayo Clinic; Dana-Farber Cancer Institute; Duke University and other collaborators

Active, not recruiting

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes

Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); University of Miami; University of Florida

Recruiting

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Pancreatic Cancer | Pancreatic Cyst

United States
Jong Hoon Lee
National Cancer Center, Korea; Samsung Medical Center; Seoul National University...

Unknown

Short-course Preoperative Chemoradiotherapy for Rectal Cancer (KROG 11-02)

Rectal Cancer

Korea, Republic of
Institut Bergonié
Ligue contre le cancer, France

Unknown

High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study (BRIFU)

Breast Cancer Female

France
Institut Bergonié
Ligue contre le cancer, France

Unknown

Brief Intervention for Tobacco and Alcohol Risk Reduction for Couple During Breast Cancer Treatment. (IBMC)

Smoking Cessation | Breast Cancer | Alcohol Use, Unspecified

France
William Jennings Bryan Dorn VA Medical Center
Congressionally Directed Medical Research Programs

Unknown

Using Heart Rate Variability Biofeedback to Improve Attention and Memory in PTSD+ Combat Veterans (HRVB)

PTSD

United States
Institut Bergonié
Ligue contre le cancer, France

Completed

Effectiveness of Screening and Brief Interventions for Alcohol and Tobacco During Breast Cancer Treatment (ONKODETOX) (ONKODETOX)

Breast Cancer | Psychology, Social

France
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Iovance Biotherapeutics, Inc.; The V Foundation...

Completed

Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma

Sarcoma

United States
Centre Hospitalier Universitaire de Saint Etienne
Ligue contre le cancer, France

Terminated

Implementation of a Tool to Identify Social Weaknesses in the Cancer Care Pathway (iDEFCO)

Cancer

France

Clinical Trials Sponsored by Leo W. Jenkins Cancer Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations